Biotech Startups
9,920 companies tagged Biotech, with their investors and founders.
Palo Santo is a venture capital firm that invests in neuroscience and mental health companies, focusing on novel CNS therapeutics, next-generation psychedelic therapies, and brain health technologies. The firm targets solutions addressing the innovation gap in mental health treatment and psychiatric disorders.
2 investors
Pandorum Technology develops tissue engineering and regenerative medicine products using proprietary stem cell and exosome platforms to address corneal dystrophies, lung disorders, and liver diseases. The company creates bio-engineered functional tissues through cell engineering, 3D printing, and cell-free therapies for medical research and therapeutic applications.
2 investors
Pangea Bio develops therapies targeting central nervous system and mental health disorders by activating the TrkB receptor pathway to promote neuronal survival and synaptic plasticity. The company serves patients with neurological and mental health conditions.
2 investors
Panome Bio provides metabolomics, proteomics, and multi-omics integration workflows along with a computational platform that analyzes and integrates diverse biological data types. It serves life science and biotechnology researchers looking to identify biomarkers and generate research insights.
2 investors
Paradigm develops diagnostic tests for cancer, including assessments of hereditary risk, screening for the presence of cancer, and analysis of the genomic alterations in a patient's tumor to help guide treatment decisions. The company operates in the cancer diagnostics and genomics industry.
2 investors
Industry-leading private-equity backed CDMO focused on development and manufacturing of cutting-edge biopharmaceuticals
2 investors
Parexel is a contract research organization (CRO) providing clinical development, regulatory consulting, and market access services for biopharmaceutical companies conducting clinical trials across phases I-IV globally. The company operates with a network of offices and specialized facilities across North America, Latin America, Europe, and Asia-Pacific.
2 investors
Patheon, part of Thermo Fisher Scientific, is a contract development and manufacturing organization (CDMO) that also offers clinical research (CRO) services for biotechnology and pharmaceutical sponsors. It supports drug development from early-stage R&D through clinical supply and commercial manufacturing across a global network of more than 60 sites.
2 investors
Path Fertility develops diagnostic tests for male reproductive health, using sperm epigenetics technology to identify subfertility that standard analysis misses. The tests enable earlier and more accurate diagnosis for couples pursuing fertility treatment.
2 investors
PathoQuest develops iDTECT, a platform of Next Generation Sequencing (NGS) assays for biopharmaceutical quality control, offering animal-free viral safety testing and genetic characterization of cell banks and biologics. The company was acquired by Charles River Labs to expand its end-to-end biologics testing portfolio.
2 investors
PathoScan provides portable, field-deployable pathogen detection technology for agronomists and growers, enabling rapid diagnosis of crop diseases within hours rather than days.
2 investors
Pathotrak develops foodborne pathogen detection kits and a next-generation enrichment platform for food safety testing labs, offering fast time-to-results across sample types such as fresh produce, beef, poultry, and environmental swabs. Its products are designed to be USDA and FDA compliant.
2 investors
Pattern develops rapid antibiotic susceptibility and infection diagnostics using single-cell microbiology, which reads the metabolic patterns of individual bacterial cells to deliver ID/AST results in hours without culture steps. Its phenotypic testing targets common infection sites to support faster, more focused antibiotic treatment in hospitals and combat antibiotic resistance.
2 investors
2 investors
Pensees develops cultivated meat produced by growing animal cells, using its patented 3D bioprinting technology. The company positions cultivated meat as a sustainable alternative for meat production.
2 investors
PEP-Therapy develops peptide-based therapeutic candidates for oncology, with a lead product in clinical trials targeting solid tumors including ovarian cancer and pancreatic cancer. The company uses an intracellular delivery technology platform to deliver peptides that restore apoptosis in cancer cells.
2 investors
PepGen is a clinical-stage biotech company developing oligonucleotide therapies for neuromuscular and neurological diseases using its Enhanced Delivery Oligonucleotide (EDO) platform to improve tissue penetration and uptake in muscle tissues.
2 investors
Platform accelerating drug discovery for untreatable diseases.
2 investors
Peptinovo develops PALM™, a targeted drug-delivery platform that encapsulates chemotherapy drugs to deliver them directly to cancer cells while sparing healthy tissue, reducing side effects and enabling higher therapeutic doses. The technology mimics HDL cholesterol carriers that cancer cells naturally uptake, allowing selective destruction of tumors with improved safety profiles.
2 investors
Peptobiotics designs synthetic antimicrobial peptides intended to treat bacterial infections in farm animals. The peptides are made using cell-free production methods, which the company says avoids drug residues in animal products. The aim is to give livestock producers an alternative to conventional antibiotics and limit the spread of antimicrobial resistance.
2 investors
Peptomyc is a biotech company developing MYC inhibitors for cancer treatment, based on the Omomyc molecule, and is advancing them through preclinical and clinical trials. It operates in oncology drug development, with its research group linked to the Vall d'Hebron Institute of Oncology in Barcelona, Spain.
2 investors
Peregrine is a global life science venture capital fund that invests in healthcare companies through strategic synergistic investments. The firm partners with entrepreneurs and established healthcare institutions to develop innovations that improve health outcomes and healthcare economics.
2 investors
PerioTrap develops a microbiome-friendly toothpaste that selectively targets harmful oral bacteria while preserving beneficial bacteria, using patented PerioTrap® technology designed to reduce gum inflammation risk. The company manufactures products in Germany for consumers seeking targeted gum health support.
2 investors
Perosphere is a medical technology company developing point-of-care coagulation diagnostics, including a pharmacodynamic test that provides a global view of a patient's coagulation status. Its lead product is CE Marked in the European Union but not FDA cleared in the United States.
2 investors